BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 990 filers reported holding BAXTER INTL INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,715 | -17.2% | 45,460 | 0.0% | 0.02% | -15.0% |
| Q2 2023 | $2,072 | +6.6% | 45,460 | -5.1% | 0.02% | +5.3% |
| Q1 2023 | $1,943 | -20.4% | 47,902 | 0.0% | 0.02% | -26.9% |
| Q4 2022 | $2,442 | -100.0% | 47,902 | -69.0% | 0.03% | -73.2% |
| Q3 2022 | $8,315,000 | -21.3% | 154,386 | +13.4% | 0.10% | -5.8% |
| Q1 2022 | $10,560,000 | -10.7% | 136,183 | -1.1% | 0.10% | -1.9% |
| Q4 2021 | $11,822,000 | +4.6% | 137,721 | -2.0% | 0.10% | 0.0% |
| Q3 2021 | $11,306,000 | -0.1% | 140,572 | 0.0% | 0.10% | +1.0% |
| Q2 2021 | $11,316,000 | -6.8% | 140,572 | -2.3% | 0.10% | -13.3% |
| Q1 2021 | $12,138,000 | -1.5% | 143,928 | -6.3% | 0.12% | -2.4% |
| Q4 2020 | $12,324,000 | -4.0% | 153,595 | -3.8% | 0.12% | -15.8% |
| Q3 2020 | $12,837,000 | -8.1% | 159,622 | -1.6% | 0.15% | -12.0% |
| Q2 2020 | $13,965,000 | -1.3% | 162,185 | -6.9% | 0.17% | -16.6% |
| Q1 2020 | $14,146,000 | -7.4% | 174,227 | -4.7% | 0.20% | +17.8% |
| Q4 2019 | $15,281,000 | -4.4% | 182,741 | 0.0% | 0.17% | -12.0% |
| Q3 2019 | $15,984,000 | +8.6% | 182,741 | +1.7% | 0.19% | +7.3% |
| Q2 2019 | $14,721,000 | -2.3% | 179,741 | -3.0% | 0.18% | -3.8% |
| Q1 2019 | $15,062,000 | +17.4% | 185,241 | -5.0% | 0.19% | +5.1% |
| Q4 2018 | $12,831,000 | -2.0% | 194,955 | +14.7% | 0.18% | +12.7% |
| Q3 2018 | $13,098,000 | -6.0% | 169,912 | -10.0% | 0.16% | -4.8% |
| Q2 2018 | $13,933,000 | +43.8% | 188,694 | +26.6% | 0.16% | +41.0% |
| Q1 2018 | $9,691,000 | -5.0% | 148,990 | -5.6% | 0.12% | -2.5% |
| Q4 2017 | $10,197,000 | +3.0% | 157,752 | 0.0% | 0.12% | +0.8% |
| Q3 2017 | $9,899,000 | +15.9% | 157,752 | +11.9% | 0.12% | +11.2% |
| Q2 2017 | $8,539,000 | +197.7% | 141,031 | +155.0% | 0.11% | +197.2% |
| Q1 2017 | $2,868,000 | +9.8% | 55,300 | -6.1% | 0.04% | +9.1% |
| Q4 2016 | $2,612,000 | -26.3% | 58,900 | -20.9% | 0.03% | -26.7% |
| Q3 2016 | $3,546,000 | +5.3% | 74,500 | 0.0% | 0.04% | +2.3% |
| Q2 2016 | $3,369,000 | +10.1% | 74,500 | 0.0% | 0.04% | +10.0% |
| Q1 2016 | $3,060,000 | +7.7% | 74,500 | 0.0% | 0.04% | +11.1% |
| Q4 2015 | $2,842,000 | +16.1% | 74,500 | 0.0% | 0.04% | +12.5% |
| Q3 2015 | $2,447,000 | -53.0% | 74,500 | 0.0% | 0.03% | -48.4% |
| Q2 2015 | $5,210,000 | -4.2% | 74,500 | -6.2% | 0.06% | -1.6% |
| Q1 2015 | $5,439,000 | -10.3% | 79,400 | -4.0% | 0.06% | -8.7% |
| Q4 2014 | $6,061,000 | -57.9% | 82,700 | -58.8% | 0.07% | -59.6% |
| Q3 2014 | $14,411,000 | -3.3% | 200,800 | -2.6% | 0.17% | -1.2% |
| Q2 2014 | $14,901,000 | -39.4% | 206,100 | -38.3% | 0.17% | -40.3% |
| Q1 2014 | $24,575,000 | -0.5% | 334,000 | -5.9% | 0.29% | +1.0% |
| Q4 2013 | $24,697,000 | +4.8% | 355,100 | -1.0% | 0.29% | +33.5% |
| Q3 2013 | $23,557,000 | -28.1% | 358,600 | -24.2% | 0.22% | -30.6% |
| Q2 2013 | $32,758,000 | – | 472,900 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
| GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
| Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
| Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
| Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
| Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
| TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
| CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
| Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
| Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |